Abilify injection discontinued

term, placebo-controlled trials, but did not lead to discontinuation of any adult patients on. ABILIFY Injection. ABILIFY may make you drowsy. Avoid

Aripiprazole extended release injection (Abilify Maintena) injection loading doses to ALL patients regardless of oral dose. Discontinue.

The dose should be administered by intramuscular injection in the gluteal muscle by a health care professional. Consider discontinuing Abilify

Discontinue ABILIFY MAINTENA at the first sign of a clinically significant Injection Site Reactions: In a short-term, clinical trial with ABILIFY MAINTENA

Otsuka has discontinued Abilify Discmelt oral disintegrating tablets. The company has also discontinued the oral solution and injection. Trigen introduced aripiprazole oral disintegrating tablets in 2024. Abilify oral tablets and generic aripiprazole oral tablets are not affected.

agitation associated with schizophrenia or bipolar mania in adults (the injectable form only, product now discontinued in the US). Abilify

Discontinuation of Abilify Maintena​​ If Abilify Maintena is discontinued, its prolonged-release characteristics must be considered.

injections of 400 mg Abilify Maintena at separate injection sites, along wi th Aripiprazole must be discontinued If a patient develops signs and sym

960 mg in place of the next scheduled injection of the Abilify Maintena. Discontinuation rates due to side effects were low for both Abilify Asimtufii.